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An enzyme with self-control
U
nlike enzymes that depend on 
other proteins to rein in their 
activity, polo-like kinase 4 (Plk4) 
does the job itself. Holland et al. reveal 
that Plk4, which helps regulate centro-
some duplication, reduces its activity by 
initiating its own destruction (1). By 
sacrifi  cing itself, the protein prevents cells 
from building too many centrosomes.
Cells prepare to divide by dupli-
cating the centrosome, the organelle 
that serves as a hub for the cytoskeleton 
and an anchor for the mitotic spindle. 
The problem is how to make only one 
copy before each round of cell division. 
Extra centrosomes can disrupt chro-
mosome separation during mitosis and 
might trigger cancer (2), although the 
evidence for that effect remains contro-
versial. Managing centrosome duplica-
tion is the job of Plk4, which prompts 
the pair of centrioles in the centrosome 
to replicate. Cells must carefully cali-
brate Plk4 levels because too much or 
too little of the enzyme promotes tumors 
(3, 4). In fruit fl  ies, a protein complex 
called SCF  Slimb   helps regulate Plk4’s 
abundance by ubiquitinating phospho-
rylated copies of the enzyme, spurring 
their demolition by the proteasome (5). 
Mammals carry an equivalent to SCF  Slimb  
known as SCF  -TrCP  , but other aspects of 
the mechanism that sets Plk4 levels in 
mammalian cells remain murky.
What little Plk4 cells harbor usu-
ally disappears rapidly. The enzyme 
adds phosphates to targets including 
other Plk4 molecules, suggesting that 
self-phosphorylation might spur its 
speedy demise. To test this idea, Hol-
land et al. engineered human cells to 
produce normal Plk4 or a nonfunc-
tional variant. The amount of Plk4 was 
10 times higher in cells that made the 
defective enzyme. The researchers also 
tested a Plk4 version whose phosphory-
lation ability could be shut down with 
a drug called 1NM-PP1. Adding the 
inhibitor to cells caused the amount of 
Plk4 to shoot up.
The picture that emerges from 
these experiments, the researchers say, 
is that in mammalian cells Plk4 mol-
ecules stimulate their own breakdown 
by phosphorylating each other. Whether 
an individual Plk4 molecule can affix 
phosphates to itself isn’t clear, says 
first author Andrew Holland, but he 
thinks it’s highly likely that Plk4 is auto-
phosphorylating.
The team also nailed down where 
the phosphates attach to Plk4. Previ-
ous studies identified two 
phosphate-ready amino 
acids within a region of 
the protein that attracts 
the ubiquitinating com-
plex SCF  -TrCP .  Holland 
et al. replaced these two 
amino acids with alanines, 
which can’t be phospho-
rylated and thus prevent 
SCF  -TrCP   from latching on. 
The change only modestly 
boosted Plk4’s stability, 
suggesting that additional phosphory-
lation sites help regulate Plk4 levels. 
The team located 13 such sites, spread 
across a 24–amino acid span in the pro-
tein’s midsection. Snipping out this 
segment halted Plk4’s destruction and 
dramatically increased the number of 
centrioles that cells manufacture, the 
scientists found.
“This kinase regulates its own sta-
bility to help prevent centrosome over-
duplication and genome instability,” 
says Holland. The fi  nding puts Plk4 in 
rare company. Scientists have identi-
fi  ed only one other kinase, the tyrosine 
kinase Src, that controls its own levels 
in a similar way. However, researchers 
haven’t worked out how Src’s activity 
undercuts its stability.
Several questions remain about 
Plk4 as well, such as whether other 
enzymes in addition to 
SCF  -TrCP   ubiquitinate it and 
whether other kinases help 
diminish its stability. An-
other mystery is why Plk4 
carries so many phosphory-
lation sites. Holland sug-
gests that the large number 
of sites results in a degrada-
tion delay while the enzyme 
acquires a threshold number 
of phosphates. “We think 
that [the delay] might give 
the protein the opportunity to perform its 
function before it kills itself,” he says.
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Weijie Lan (left), Don Cleveland (middle), Andrew Holland (right), and colleagues determined 
how the kinase Plk4 curbs its own levels and thus limits duplication of centrosomes. A cell with 
faulty Plk4 (right) produces multiple centrioles, indicated by the glowing dots strewn around 
the cytoplasm. The original centrioles are the bright green dots at the left edge.
“We think that 
[the delay] 
might give the 
protein the 
opportunity 
to perform its 
function before 
it kills itself.”
To keep itself in check, Plk4 encourages its own removal.
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